| Vicki Edwards |
Director European Pharmacovigilance |
Abbott |
| Bledar Haderi |
Drug Safety and Epidemiology Manager |
AstraZeneca |
| Dieter Konrad |
Manager, Department of Information Processing |
Boehringer Ingelheim |
| Saad Shakir |
Director, Drug Safety Research Unit |
Southampton UK |
| Tjeerd van Staa |
Head of Research |
General Practice Research Database (MHRA) |
| Thomas Verstraeten |
Director of Worldwide Safety and Regulatory Management |
GSK Biologicals |
| Ennis Lee |
Vice President, QPPV Pharma, Benefit Risk Management |
Janssen Cilag |
| Janet Hormbrey |
Executive Director, EU Qualified Person for Risk Management and Pharmacovigilance |
Merck & Co |
| Enrica Alteri |
Global Drug Safety, Medical Safety Group Neurology |
Merck Serono |
| Brian Edwards |
Director, Pharmacovigilance and Drug Safety |
NDA Regulatory Service |
| Gro Laier |
Deputy Qualified Person, International Product Safety |
Novo Nordisk |
| William Gregory |
Director, Safety and Risk Management |
Pfizer |
| Thys Kruger |
Medical Director EMEA |
Ranbaxy |
| Daniel Reshef |
Director, PDS Risk Management |
Roche |
| Corinne de Vries |
Professor of Pharmacoepidemiology, Department of Pharmacy and Pharmacology |
University Of Bath |
| Johan Hopstadius |
Research Engineer, Research & Development |
Uppsala Monitoring Centre |
